Preparation and phase II clinical examination of topical dosage form for treatment of carcinoma coli containing bleomycin with hydroxypropyl cellulose.
D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D002482:Cellulose / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D014594:Uterine Neoplasms / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D001761:Bleomycin; D002482:Cellulose